Home › Funds › HARVARD MANAGEMENT CO INC › MAZE

HARVARD MANAGEMENT CO INC position in MAZE

MAZE THERAPEUTICS INC · Health Care

HARVARD MANAGEMENT CO INC reported holding 48,205 shares of MAZE (MAZE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.03% of its reported portfolio and ranking #17 among its reported holdings. HARVARD MANAGEMENT CO INC has disclosed MAZE holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)48.20K sh
Reported value held$1.31M
Portfolio Weight0.03%
First reportedQ1 2025
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How HARVARD MANAGEMENT CO INC's MAZE position evolved

HARVARD MANAGEMENT CO INC first disclosed a stake in MAZE in Q1 2025 at 637,528 shares (US$7.0M). The position peaked in Q2 2025 at 637,528 shares, worth US$7.8M. Across 4 filings, HARVARD MANAGEMENT CO INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 48,205 shares valued at US$1.3M. Notable position changes include a 86% trim in Q3 2025 (shares rose 60% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 637.53K $7.02M New
Q2 2025 637.53K $7.82M Hold
Q3 2025 92.40K $2.40M Reduce
Q3 2026 48.20K $1.31M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MAZE and 13F data

MAZE (MAZE THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in MAZE — the largest reported positions include Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MAZE

All MAZE fund holders →

FAQ

How long has HARVARD MANAGEMENT CO INC held MAZE?

HARVARD MANAGEMENT CO INC has disclosed MAZE holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

What is HARVARD MANAGEMENT CO INC's current position in MAZE?

As of Q3 2026, HARVARD MANAGEMENT CO INC holds 48.20K shares of MAZE (MAZE THERAPEUTICS INC), valued at $1.31M, representing 0.03% of its reported portfolio and ranking #17.

Has HARVARD MANAGEMENT CO INC been buying or selling MAZE?

In the latest 13F filing (Q3 2026), HARVARD MANAGEMENT CO INC newly opened its position in MAZE. The position peaked in Q2 2025 at 637.53K shares.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.